1. Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM). Issue 3 (29th March 2021) Authors: Gonzalez-Cao, Maria; Puertolas, Teresa; Riveiro, Mar; Muñoz-Couselo, Eva; Ortiz, Carolina; Paredes, Roger; Podzamczer, Daniel; Manzano, Jose Luis; Molto, Jose; Revollo, Boris; Carrera, Cristina; Mateu, Lourdes; Fancelli, Sara; Espinosa, Enrique; Clotet, Bonaventura; Martinez-Picado, Javier; Cerez... Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM). Issue 3 (29th March 2021) Authors: Gonzalez-Cao, Maria; Puertolas, Teresa; Riveiro, Mar; Muñoz-Couselo, Eva; Ortiz, Carolina; Paredes, Roger; Podzamczer, Daniel; Manzano, Jose Luis; Molto, Jose; Revollo, Boris; Carrera, Cristina; Mateu, Lourdes; Fancelli, Sara; Espinosa, Enrique; Clotet, Bonaventura; Martinez-Picado, Javier; Cerez... Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study. (23rd May 2018) Authors: Capdevila, Jaume; Teulé, Alexandre; Barriuso, Jorge; Castellano, Daniel; Lopez, Carlos; Manzano, Jose Luis; Alonso, Vicente; García‐Carbonero, Rocío; Dotor, Emma; Matos, Ignacio; Custodio, Ana; Casanovas, Oriol; Salazar, Ramon Journal: Oncologist Issue: Volume 24:Number 1(2019) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗